Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients

Autor: João Roberto Antonio, Marília Silveira Faeda Augusto, Jessica Sanmiguel, Giovana Viotto Cagnon, Moacir Fernandes de Godoy, Eurides Maria de Oliveira Pozetti

Publikováno v: Anais Brasileiros de Dermatologia
Anais Brasileiros de Dermatologia v.91 n.3 2016
Anais brasileiros de dermatologia
Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
Anais Brasileiros de Dermatologia, Volume: 91, Issue: 3, Pages: 306-310, Published: JUN 2016
Anais Brasileiros de Dermatologia, Vol 91, Iss 3, Pp 306-310 (2016)

Background: Psoriasis is immune-mediated chronic inflammatory disease with preference for skin and joints. The skin involvement occurs by hyperproliferation and abnormal differentiation of keratinocytes. It is associated with comorbidities, mainly re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3242d2069bbc462999d69c1e1473e86a
https://pubmed.ncbi.nlm.nih.gov/27438197